Product Code: TMRGL85475
Atrial Fibrillation Surgery Devices Market - Scope of Report:
TMR's report on the global atrial fibrillation surgery devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global atrial fibrillation surgery devices market for the period 2017-2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global atrial fibrillation surgery devices market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the atrial fibrillation surgery devices market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global atrial fibrillation surgery devices market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global atrial fibrillation surgery devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global atrial fibrillation surgery devices market.
The report delves into the competitive landscape of the global atrial fibrillation surgery devices market. Key players operating in the global atrial fibrillation surgery devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global atrial fibrillation surgery devices market profiled in this report.
Key Questions Answered in Global Atrial Fibrillation Surgery Devices Market Report:
- What is the sales/revenue generated by atrial fibrillation surgery devices across all regions during the forecast period?
- What are the opportunities in the global atrial fibrillation surgery devices market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Atrial Fibrillation Surgery Devices Market - Research Objectives and Research Approach:
The comprehensive report on the global atrial fibrillation surgery devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global atrial fibrillation surgery devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global atrial fibrillation surgery devices market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Atrial Fibrillation Surgery Devices Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Procedure Definition
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Atrial Fibrillation Surgery Devices Market Analysis and Forecast, 2017-2031
- 4.4.1. Porter's Five Forces Analysis
5. Key Insights
- 5.1. Disease Prevalence & Incidence Rate Globally With Key Countries
- 5.2. Technological Advancements
- 5.3. Overview of Atrial Fibrillation
- 5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Atrial Fibrillation Surgery Devices Market Analysis and Forecast, by Procedure
- 6.1. Introduction & Definition
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Procedure, 2017-2031
- 6.3.1. Catheter Ablation
- 6.3.1.1. Radiofrequency Ablation
- 6.3.1.2. Cryoablation
- 6.3.2. Surgical Ablation
- 6.3.2.1. Convergent Ablation
- 6.3.2.2. Maze Ablation
- 6.4. Market Attractiveness Analysis, by Procedure
7. Global Atrial Fibrillation Surgery Devices Market Analysis and Forecast, by End-user
- 7.1. Introduction & Definition
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by End-user, 2017-2031
- 7.3.1. Hospitals
- 7.3.2. Specialty Centers
- 7.3.3. Ambulatory Surgical Centers
- 7.3.4. Others
- 7.4. Market Attractiveness Analysis, by End-user
8. Global Atrial Fibrillation Surgery Devices Market Analysis and Forecast, by Region
- 8.1. Key Findings
- 8.2. Market Value Forecast, by Region
- 8.2.1. North America
- 8.2.2. Europe
- 8.2.3. Asia Pacific
- 8.2.4. Latin America
- 8.2.5. Middle East & Africa
- 8.3. Market Attractiveness Analysis, by Region
9. North America Atrial Fibrillation Surgery Devices Market Analysis and Forecast
- 9.1. Introduction
- 9.2. Market Value Forecast, by Procedure, 2017-2031
- 9.2.1. Catheter Ablation
- 9.2.1.1. Radiofrequency Ablation
- 9.2.1.2. Cryoablation
- 9.2.2. Surgical Ablation
- 9.2.2.1. Convergent Ablation
- 9.2.2.2. Maze Ablation
- 9.3. Market Value Forecast, by End-user, 2017-2031
- 9.3.1. Hospitals
- 9.3.2. Specialty Centers
- 9.3.3. Ambulatory Surgical Centers
- 9.3.4. Others
- 9.4. Market Value Forecast, by Country, 2017-2031
- 9.4.1. U.S.
- 9.4.2. Canada
- 9.5. Market Attractiveness Analysis
- 9.5.1. By Procedure
- 9.5.2. By End-user
- 9.5.3. By Country
10. Europe Atrial Fibrillation Surgery Devices Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value Forecast, by Procedure, 2017-2031
- 10.2.1. Catheter Ablation
- 10.2.1.1. Radiofrequency Ablation
- 10.2.1.2. Cryoablation
- 10.2.2. Surgical Ablation
- 10.2.2.1. Convergent Ablation
- 10.2.2.2. Maze Ablation
- 10.3. Market Value Forecast, by End-user, 2017-2031
- 10.3.1. Hospitals
- 10.3.2. Specialty Centers
- 10.3.3. Ambulatory Surgical Centers
- 10.3.4. Others
- 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 10.4.1. Germany
- 10.4.2. U.K.
- 10.4.3. France
- 10.4.4. Italy
- 10.4.5. Spain
- 10.4.6. Rest of Europe
- 10.5. Market Attractiveness Analysis
- 10.5.1. By Procedure
- 10.5.2. By End-user
- 10.5.3. By Country/Sub-region
11. Asia Pacific Atrial Fibrillation Surgery Devices Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Procedure, 2017-2031
- 11.2.1. Catheter Ablation
- 11.2.1.1. Radiofrequency Ablation
- 11.2.1.2. Cryoablation
- 11.2.2. Surgical Ablation
- 11.2.2.1. Convergent Ablation
- 11.2.2.2. Maze Ablation
- 11.3. Market Value Forecast, by End-user, 2017-2031
- 11.3.1. Hospitals
- 11.3.2. Specialty Centers
- 11.3.3. Ambulatory Surgical Centers
- 11.3.4. Others
- 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.4.1. China
- 11.4.2. Japan
- 11.4.3. India
- 11.4.4. Australia & New Zealand
- 11.4.5. Rest of Asia Pacific
- 11.5. Market Attractiveness Analysis
- 11.5.1. By Procedure
- 11.5.2. By End-user
- 11.5.3. By Country/Sub-region
12. Latin America Atrial Fibrillation Surgery Devices Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Procedure, 2017-2031
- 12.2.1. Catheter Ablation
- 12.2.1.1. Radiofrequency Ablation
- 12.2.1.2. Cryoablation
- 12.2.2. Surgical Ablation
- 12.2.2.1. Convergent Ablation
- 12.2.2.2. Maze Ablation
- 12.3. Market Value Forecast, by End-user, 2017-2031
- 12.3.1. Hospitals
- 12.3.2. Specialty Centers
- 12.3.3. Ambulatory Surgical Centers
- 12.3.4. Others
- 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.4.1. Brazil
- 12.4.2. Mexico
- 12.4.3. Rest of Latin America
- 12.5. Market Attractiveness Analysis
- 12.5.1. By Procedure
- 12.5.2. By End-user
- 12.5.3. By Country/Sub-region
13. Middle East & Africa Atrial Fibrillation Surgery Devices Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Procedure, 2017-2031
- 13.2.1. Catheter Ablation
- 13.2.1.1. Radiofrequency Ablation
- 13.2.1.2. Cryoablation
- 13.2.2. Surgical Ablation
- 13.2.2.1. Convergent Ablation
- 13.2.2.2. Maze Ablation
- 13.3. Market Value Forecast, by End-user, 2017-2031
- 13.3.1. Hospitals
- 13.3.2. Specialty Centers
- 13.3.3. Ambulatory Surgical Centers
- 13.3.4. Others
- 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.4.1. GCC Countries
- 13.4.2. South Africa
- 13.4.3. Rest of Middle East & Africa
- 13.5. Market Attractiveness Analysis
- 13.5.1. By Procedure
- 13.5.2. By End-user
- 13.5.3. By Country/Sub-region
14. Competition Landscape
- 14.1. Market Player - Competition Matrix (by tier and size of companies)
- 14.2. Market Share Analysis, by Company (2022)
- 14.3. Company Profiles
- 14.3.1. AtriCure, Inc.
- 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.1.2. Product Portfolio
- 14.3.1.3. Financial Overview
- 14.3.1.4. SWOT Analysis
- 14.3.1.5. Strategic Overview
- 14.3.2. CardioFocus, Inc.
- 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.2.2. Product Portfolio
- 14.3.2.3. Financial Overview
- 14.3.2.4. SWOT Analysis
- 14.3.2.5. Strategic Overview
- 14.3.3. Abbott Laboratories
- 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.3.2. Product Portfolio
- 14.3.3.3. Financial Overview
- 14.3.3.4. SWOT Analysis
- 14.3.3.5. Strategic Overview
- 14.3.4. Biosense Webster, Inc.
- 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.4.2. Product Portfolio
- 14.3.4.3. Financial Overview
- 14.3.4.4. SWOT Analysis
- 14.3.4.5. Strategic Overview
- 14.3.5. Medtronic plc
- 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.5.2. Product Portfolio
- 14.3.5.3. Financial Overview
- 14.3.5.4. SWOT Analysis
- 14.3.6. Boston Scientific Corporation
- 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.6.2. Product Portfolio
- 14.3.6.3. Financial Overview
- 14.3.6.4. SWOT Analysis
- 14.3.7. Osypka AG
- 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.7.2. Product Portfolio
- 14.3.7.3. Financial Overview
- 14.3.7.4. SWOT Analysis
- 14.3.8. Kardium, Inc.
- 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.8.2. Product Portfolio
- 14.3.8.3. Financial Overview
- 14.3.8.4. SWOT Analysis
- 14.3.9. Acutus Medical, Inc.
- 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.9.2. Product Portfolio
- 14.3.9.3. Financial Overview
- 14.3.9.4. SWOT Analysis
- 14.3.10. Koninklijke Philips N.V.
- 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.10.2. Product Portfolio
- 14.3.10.3. Financial Overview
- 14.3.10.4. SWOT Analysis
- 14.3.10.5. Strategic Overview